Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Chemotherapy-Induced Neutropenia Treatment Market Size Growth Rate by Type (2014-2025) 1.4.2 Antibiotic Therapy 1.4.3 Colony-Stimulating Factor Therapy 1.4.4 Granulocyte Transfusion 1.4.5 Splenectomy Procedure 1.4.6 Others 1.5 Market by Application 1.5.1 Global Chemotherapy-Induced Neutropenia Treatment Market Share by Application (2014-2025) 1.5.2 Hospital Pharmacy 1.5.3 Retail Pharmacy 1.5.4 Online Pharmacy 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Chemotherapy-Induced Neutropenia Treatment Market Size 2.2 Chemotherapy-Induced Neutropenia Treatment Growth Trends by Regions 2.2.1 Chemotherapy-Induced Neutropenia Treatment Market Size by Regions (2014-2025) 2.2.2 Chemotherapy-Induced Neutropenia Treatment Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Chemotherapy-Induced Neutropenia Treatment Market Size by Manufacturers 3.1.1 Global Chemotherapy-Induced Neutropenia Treatment Revenue by Manufacturers (2014-2018) 3.1.2 Global Chemotherapy-Induced Neutropenia Treatment Revenue Market Share by Manufacturers (2014-2018) 3.1.3 Global Chemotherapy-Induced Neutropenia Treatment Market Concentration Ratio (CR5 and HHI) 3.2 Chemotherapy-Induced Neutropenia Treatment Key Players Head office and Area Served 3.3 Key Players Chemotherapy-Induced Neutropenia Treatment Product/Solution/Service 3.4 Date of Enter into Chemotherapy-Induced Neutropenia Treatment Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Chemotherapy-Induced Neutropenia Treatment Market Size by Type (2014-2019) 4.2 Global Chemotherapy-Induced Neutropenia Treatment Market Size by Application (2014-2019) 5 United States 5.1 United States Chemotherapy-Induced Neutropenia Treatment Market Size (2014-2019) 5.2 Chemotherapy-Induced Neutropenia Treatment Key Players in United States 5.3 United States Chemotherapy-Induced Neutropenia Treatment Market Size by Type 5.4 United States Chemotherapy-Induced Neutropenia Treatment Market Size by Application 6 Europe 6.1 Europe Chemotherapy-Induced Neutropenia Treatment Market Size (2014-2019) 6.2 Chemotherapy-Induced Neutropenia Treatment Key Players in Europe 6.3 Europe Chemotherapy-Induced Neutropenia Treatment Market Size by Type 6.4 Europe Chemotherapy-Induced Neutropenia Treatment Market Size by Application 7 China 7.1 China Chemotherapy-Induced Neutropenia Treatment Market Size (2014-2019) 7.2 Chemotherapy-Induced Neutropenia Treatment Key Players in China 7.3 China Chemotherapy-Induced Neutropenia Treatment Market Size by Type 7.4 China Chemotherapy-Induced Neutropenia Treatment Market Size by Application 8 Japan 8.1 Japan Chemotherapy-Induced Neutropenia Treatment Market Size (2014-2019) 8.2 Chemotherapy-Induced Neutropenia Treatment Key Players in Japan 8.3 Japan Chemotherapy-Induced Neutropenia Treatment Market Size by Type 8.4 Japan Chemotherapy-Induced Neutropenia Treatment Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Chemotherapy-Induced Neutropenia Treatment Market Size (2014-2019) 9.2 Chemotherapy-Induced Neutropenia Treatment Key Players in Southeast Asia 9.3 Southeast Asia Chemotherapy-Induced Neutropenia Treatment Market Size by Type 9.4 Southeast Asia Chemotherapy-Induced Neutropenia Treatment Market Size by Application 10 India 10.1 India Chemotherapy-Induced Neutropenia Treatment Market Size (2014-2019) 10.2 Chemotherapy-Induced Neutropenia Treatment Key Players in India 10.3 India Chemotherapy-Induced Neutropenia Treatment Market Size by Type 10.4 India Chemotherapy-Induced Neutropenia Treatment Market Size by Application 11 Central & South America 11.1 Central & South America Chemotherapy-Induced Neutropenia Treatment Market Size (2014-2019) 11.2 Chemotherapy-Induced Neutropenia Treatment Key Players in Central & South America 11.3 Central & South America Chemotherapy-Induced Neutropenia Treatment Market Size by Type 11.4 Central & South America Chemotherapy-Induced Neutropenia Treatment Market Size by Application 12 International Players Profiles 12.1 Amgen 12.1.1 Amgen Company Details 12.1.2 Company Description and Business Overview 12.1.3 Chemotherapy-Induced Neutropenia Treatment Introduction 12.1.4 Amgen Revenue in Chemotherapy-Induced Neutropenia Treatment Business (2014-2019) 12.1.5 Amgen Recent Development 12.2 Sanofi 12.2.1 Sanofi Company Details 12.2.2 Company Description and Business Overview 12.2.3 Chemotherapy-Induced Neutropenia Treatment Introduction 12.2.4 Sanofi Revenue in Chemotherapy-Induced Neutropenia Treatment Business (2014-2019) 12.2.5 Sanofi Recent Development 12.3 Novartis 12.3.1 Novartis Company Details 12.3.2 Company Description and Business Overview 12.3.3 Chemotherapy-Induced Neutropenia Treatment Introduction 12.3.4 Novartis Revenue in Chemotherapy-Induced Neutropenia Treatment Business (2014-2019) 12.3.5 Novartis Recent Development 12.4 Baxter International 12.4.1 Baxter International Company Details 12.4.2 Company Description and Business Overview 12.4.3 Chemotherapy-Induced Neutropenia Treatment Introduction 12.4.4 Baxter International Revenue in Chemotherapy-Induced Neutropenia Treatment Business (2014-2019) 12.4.5 Baxter International Recent Development 12.5 Teva Pharmaceuticals Industries 12.5.1 Teva Pharmaceuticals Industries Company Details 12.5.2 Company Description and Business Overview 12.5.3 Chemotherapy-Induced Neutropenia Treatment Introduction 12.5.4 Teva Pharmaceuticals Industries Revenue in Chemotherapy-Induced Neutropenia Treatment Business (2014-2019) 12.5.5 Teva Pharmaceuticals Industries Recent Development 12.6 Apotex 12.6.1 Apotex Company Details 12.6.2 Company Description and Business Overview 12.6.3 Chemotherapy-Induced Neutropenia Treatment Introduction 12.6.4 Apotex Revenue in Chemotherapy-Induced Neutropenia Treatment Business (2014-2019) 12.6.5 Apotex Recent Development 12.7 Dr.Reddy’S Laboratory 12.7.1 Dr.Reddy’S Laboratory Company Details 12.7.2 Company Description and Business Overview 12.7.3 Chemotherapy-Induced Neutropenia Treatment Introduction 12.7.4 Dr.Reddy’S Laboratory Revenue in Chemotherapy-Induced Neutropenia Treatment Business (2014-2019) 12.7.5 Dr.Reddy’S Laboratory Recent Development 12.8 Biogenomics 12.8.1 Biogenomics Company Details 12.8.2 Company Description and Business Overview 12.8.3 Chemotherapy-Induced Neutropenia Treatment Introduction 12.8.4 Biogenomics Revenue in Chemotherapy-Induced Neutropenia Treatment Business (2014-2019) 12.8.5 Biogenomics Recent Development 12.9 Ligand Pharmaceuticals 12.9.1 Ligand Pharmaceuticals Company Details 12.9.2 Company Description and Business Overview 12.9.3 Chemotherapy-Induced Neutropenia Treatment Introduction 12.9.4 Ligand Pharmaceuticals Revenue in Chemotherapy-Induced Neutropenia Treatment Business (2014-2019) 12.9.5 Ligand Pharmaceuticals Recent Development 12.10 NAL Pharmaceuticals 12.10.1 NAL Pharmaceuticals Company Details 12.10.2 Company Description and Business Overview 12.10.3 Chemotherapy-Induced Neutropenia Treatment Introduction 12.10.4 NAL Pharmaceuticals Revenue in Chemotherapy-Induced Neutropenia Treatment Business (2014-2019) 12.10.5 NAL Pharmaceuticals Recent Development 12.11 Coherus BioSciences 12.12 Intas Pharmaceuticals 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Chemotherapy-Induced Neutropenia Treatment Key Market Segments Table Key Players Chemotherapy-Induced Neutropenia Treatment Covered Table Global Chemotherapy-Induced Neutropenia Treatment Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Chemotherapy-Induced Neutropenia Treatment Market Size Market Share by Type 2014-2025 Figure Antibiotic Therapy Figures Table Key Players of Antibiotic Therapy Figure Colony-Stimulating Factor Therapy Figures Table Key Players of Colony-Stimulating Factor Therapy Figure Granulocyte Transfusion Figures Table Key Players of Granulocyte Transfusion Figure Splenectomy Procedure Figures Table Key Players of Splenectomy Procedure Figure Others Figures Table Key Players of Others Table Global Chemotherapy-Induced Neutropenia Treatment Market Size Growth by Application 2014-2025 (Million US$) Figure Hospital Pharmacy Case Studies Figure Retail Pharmacy Case Studies Figure Online Pharmacy Case Studies Figure Chemotherapy-Induced Neutropenia Treatment Report Years Considered Table Global Chemotherapy-Induced Neutropenia Treatment Market Size 2014-2025 (Million US$) Figure Global Chemotherapy-Induced Neutropenia Treatment Market Size and Growth Rate 2014-2025 (Million US$) Table Global Chemotherapy-Induced Neutropenia Treatment Market Size by Regions 2014-2025 (Million US$) Table Global Chemotherapy-Induced Neutropenia Treatment Market Size by Regions 2014-2019 (Million US$) Table Global Chemotherapy-Induced Neutropenia Treatment Market Share by Regions 2014-2019 Figure Global Chemotherapy-Induced Neutropenia Treatment Market Share by Regions 2014-2019 Figure Global Chemotherapy-Induced Neutropenia Treatment Market Share by Regions 2019 Table Market Top Trends Table Global Chemotherapy-Induced Neutropenia Treatment Revenue by Manufacturers (2014-2019) (Million US$) Table Global Chemotherapy-Induced Neutropenia Treatment Market Share by Manufacturers (2014-2019) Figure Global Chemotherapy-Induced Neutropenia Treatment Market Share by Manufacturers in 2018 Table Global Chemotherapy-Induced Neutropenia Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Chemotherapy-Induced Neutropenia Treatment Product/Solution/Service Table Date of Enter into Chemotherapy-Induced Neutropenia Treatment Market Table Mergers & Acquisitions, Expansion Plans Table Global Chemotherapy-Induced Neutropenia Treatment Market Size by Type (2014-2019) (Million US$) Table Global Chemotherapy-Induced Neutropenia Treatment Market Size Share by Type (2014-2019) Figure Global Chemotherapy-Induced Neutropenia Treatment Market Size Market Share by Type (2014-2019) Table Global Chemotherapy-Induced Neutropenia Treatment Market Size by Application (2014-2019) (Million US$) Table Global Chemotherapy-Induced Neutropenia Treatment Market Size Share by Application (2014-2019) Figure Global Chemotherapy-Induced Neutropenia Treatment Market Size Market Share by Application (2014-2019) Figure Global Chemotherapy-Induced Neutropenia Treatment Revenue Market Share by Application in 2018 Figure United States Chemotherapy-Induced Neutropenia Treatment Market Size 2014-2019 (Million US$) Table United States Key Players Chemotherapy-Induced Neutropenia Treatment Revenue (2018-2019) (Million US$) Table United States Key Players Chemotherapy-Induced Neutropenia Treatment Market Share (2018-2019) Table United States Chemotherapy-Induced Neutropenia Treatment Market Size by Type (2014-2019) (Million US$) Table United States Chemotherapy-Induced Neutropenia Treatment Market Share by Type (2014-2019) Table United States Chemotherapy-Induced Neutropenia Treatment Market Size by Application (2014-2019) (Million US$) Table United States Chemotherapy-Induced Neutropenia Treatment Market Share by Application (2014-2019) Figure Europe Chemotherapy-Induced Neutropenia Treatment Market Size 2014-2019 (Million US$) Table Europe Key Players Chemotherapy-Induced Neutropenia Treatment Revenue (2018-2019) (Million US$) Table Europe Key Players Chemotherapy-Induced Neutropenia Treatment Market Share (2018-2019) Table Europe Chemotherapy-Induced Neutropenia Treatment Market Size by Type (2014-2019) (Million US$) Table Europe Chemotherapy-Induced Neutropenia Treatment Market Share by Type (2014-2019) Table Europe Chemotherapy-Induced Neutropenia Treatment Market Size by Application (2014-2019) (Million US$) Table Europe Chemotherapy-Induced Neutropenia Treatment Market Share by Application (2014-2019) Figure China Chemotherapy-Induced Neutropenia Treatment Market Size 2014-2019 (Million US$) Table China Key Players Chemotherapy-Induced Neutropenia Treatment Revenue (2018-2019) (Million US$) Table China Key Players Chemotherapy-Induced Neutropenia Treatment Market Share (2018-2019) Table China Chemotherapy-Induced Neutropenia Treatment Market Size by Type (2014-20189) (Million US$) Table China Chemotherapy-Induced Neutropenia Treatment Market Share by Type (2014-2019) Table China Chemotherapy-Induced Neutropenia Treatment Market Size by Application (2014-2019) (Million US$) Table China Chemotherapy-Induced Neutropenia Treatment Market Share by Application (2014-2019) Figure Japan Chemotherapy-Induced Neutropenia Treatment Market Size 2014-2019 (Million US$) Table Japan Key Players Chemotherapy-Induced Neutropenia Treatment Revenue (2018-2019) (Million US$) Table Japan Key Players Chemotherapy-Induced Neutropenia Treatment Market Share (2018-2019) Table Japan Chemotherapy-Induced Neutropenia Treatment Market Size by Type (2014-2019) (Million US$) Table Japan Chemotherapy-Induced Neutropenia Treatment Market Share by Type (2014-2019) Table Japan Chemotherapy-Induced Neutropenia Treatment Market Size by Application (2014-2019) (Million US$) Table Japan Chemotherapy-Induced Neutropenia Treatment Market Share by Application (2014-2019) Figure Southeast Asia Chemotherapy-Induced Neutropenia Treatment Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Chemotherapy-Induced Neutropenia Treatment Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Chemotherapy-Induced Neutropenia Treatment Market Share (2018-2019) Table Southeast Asia Chemotherapy-Induced Neutropenia Treatment Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Chemotherapy-Induced Neutropenia Treatment Market Share by Type (2014-2019) Table Southeast Asia Chemotherapy-Induced Neutropenia Treatment Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Chemotherapy-Induced Neutropenia Treatment Market Share by Application (2014-2019) Figure India Chemotherapy-Induced Neutropenia Treatment Market Size 2014-2019 (Million US$) Table India Key Players Chemotherapy-Induced Neutropenia Treatment Revenue (2018-2019) (Million US$) Table India Key Players Chemotherapy-Induced Neutropenia Treatment Market Share (2018-2019) Table India Chemotherapy-Induced Neutropenia Treatment Market Size by Type (2014-2019) (Million US$) Table India Chemotherapy-Induced Neutropenia Treatment Market Share by Type (2014-2019) Table India Chemotherapy-Induced Neutropenia Treatment Market Size by Application (2014-2019) (Million US$) Table India Chemotherapy-Induced Neutropenia Treatment Market Share by Application (2014-2019) Figure Central & South America Chemotherapy-Induced Neutropenia Treatment Market Size 2014-2019 (Million US$) Table Central & South America Key Players Chemotherapy-Induced Neutropenia Treatment Revenue (2018-2019) (Million US$) Table Central & South America Key Players Chemotherapy-Induced Neutropenia Treatment Market Share (2018-2019) Table Central & South America Chemotherapy-Induced Neutropenia Treatment Market Size by Type (2014-2019) (Million US$) Table Central & South America Chemotherapy-Induced Neutropenia Treatment Market Share by Type (2014-2019) Table Central & South America Chemotherapy-Induced Neutropenia Treatment Market Size by Application (2014-2019) (Million US$) Table Central & South America Chemotherapy-Induced Neutropenia Treatment Market Share by Application (2014-2019) Table Amgen Company Details Table Amgen Revenue in Chemotherapy-Induced Neutropenia Treatment Business (2014-2019) (Million US$) Figure Amgen Revenue Growth Rate in Chemotherapy-Induced Neutropenia Treatment Business (2014-2019) Table Amgen Recent Development Table Sanofi Company Details Table Sanofi Revenue in Chemotherapy-Induced Neutropenia Treatment Business (2014-2019)(Million US$) Figure Sanofi Revenue Growth Rate in Chemotherapy-Induced Neutropenia Treatment Business (2014-2019) Table Sanofi Recent Development Table Novartis Company Details Table Novartis Revenue in Chemotherapy-Induced Neutropenia Treatment Business (2014-2019)(Million US$) Figure Novartis Revenue Growth Rate in Chemotherapy-Induced Neutropenia Treatment Business (2014-2019) Table Novartis Recent Development Table Baxter International Company Details Table Baxter International Revenue in Chemotherapy-Induced Neutropenia Treatment Business (2014-2019)(Million US$) Figure Baxter International Revenue Growth Rate in Chemotherapy-Induced Neutropenia Treatment Business (2014-2019) Table Baxter International Recent Development Table Teva Pharmaceuticals Industries Company Details Table Teva Pharmaceuticals Industries Revenue in Chemotherapy-Induced Neutropenia Treatment Business (2014-2019)(Million US$) Figure Teva Pharmaceuticals Industries Revenue Growth Rate in Chemotherapy-Induced Neutropenia Treatment Business (2014-2019) Table Teva Pharmaceuticals Industries Recent Development Table Apotex Company Details Table Apotex Revenue in Chemotherapy-Induced Neutropenia Treatment Business (2014-2019)(Million US$) Figure Apotex Revenue Growth Rate in Chemotherapy-Induced Neutropenia Treatment Business (2014-2019) Table Apotex Recent Development Table Dr.Reddy’S Laboratory Company Details Table Dr.Reddy’S Laboratory Revenue in Chemotherapy-Induced Neutropenia Treatment Business (2014-2019)(Million US$) Figure Dr.Reddy’S Laboratory Revenue Growth Rate in Chemotherapy-Induced Neutropenia Treatment Business (2014-2019) Table Dr.Reddy’S Laboratory Recent Development Table Biogenomics Company Details Table Biogenomics Revenue in Chemotherapy-Induced Neutropenia Treatment Business (2014-2019)(Million US$) Figure Biogenomics Revenue Growth Rate in Chemotherapy-Induced Neutropenia Treatment Business (2014-2019) Table Biogenomics Recent Development Table Ligand Pharmaceuticals Company Details Table Ligand Pharmaceuticals Revenue in Chemotherapy-Induced Neutropenia Treatment Business (2014-2019)(Million US$) Figure Ligand Pharmaceuticals Revenue Growth Rate in Chemotherapy-Induced Neutropenia Treatment Business (2014-2019) Table Ligand Pharmaceuticals Recent Development Table NAL Pharmaceuticals Company Details Table NAL Pharmaceuticals Revenue in Chemotherapy-Induced Neutropenia Treatment Business (2014-2019)(Million US$) Figure NAL Pharmaceuticals Revenue Growth Rate in Chemotherapy-Induced Neutropenia Treatment Business (2014-2019) Table NAL Pharmaceuticals Recent Development Table Coherus BioSciences Company Details Table Intas Pharmaceuticals Company Details Table Global Chemotherapy-Induced Neutropenia Treatment Market Size by Regions (Million US$) 2019-2025 Figure Global Chemotherapy-Induced Neutropenia Treatment Market Size Share by Regions (2019-2025) Figure Global Chemotherapy-Induced Neutropenia Treatment Market Size Share by Regions in 2025 Figure United States Chemotherapy-Induced Neutropenia Treatment Market Size Forecast (2019-2025)(Million USD) Figure Europe Chemotherapy-Induced Neutropenia Treatment Market Size Forecast (2019-2025)(Million USD) Figure China Chemotherapy-Induced Neutropenia Treatment Market Size Forecast (2019-2025)(Million USD) Figure Japan Chemotherapy-Induced Neutropenia Treatment Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Chemotherapy-Induced Neutropenia Treatment Market Size Forecast (2019-2025)(Million USD) Figure India Chemotherapy-Induced Neutropenia Treatment Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Chemotherapy-Induced Neutropenia Treatment Market Size Forecast (2019-2025)(Million USD) Table Global Chemotherapy-Induced Neutropenia Treatment Market Size by Product (2019-2025) (Million US$) Figure Global Chemotherapy-Induced Neutropenia Treatment Market Size by Product (2019-2025) Figure Global Chemotherapy-Induced Neutropenia Treatment Market Size by Product in 2025 Table Global Chemotherapy-Induced Neutropenia Treatment Market Size by Application (2019-2025) (Million US$) Figure Global Chemotherapy-Induced Neutropenia Treatment Market Size by Application (2019-2025) Figure Global Chemotherapy-Induced Neutropenia Treatment Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Amgen Sanofi Novartis Baxter International Teva Pharmaceuticals Industries Apotex Dr.Reddy’S Laboratory Biogenomics Ligand Pharmaceuticals NAL Pharmaceuticals Coherus BioSciences Intas Pharmaceuticals